VENTURE LIFE GROUP PLC

Board/Management Information • May 4, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1141E

Venture Life Group PLC

04 May 2017

Venture Life Group plc

("Venture Life" or the "Company")

Change of Adviser

Venture Life (AIM: VLG), the international consumer self-care group focused on developing, manufacturing and commercialising products for the ageing population, announces that it has appointed Northland Capital Partners as its nominated adviser and joint broker with immediate effect.

For further information please contact:

Venture Life Group PLC		+44 (0) 1344 742870
Jerry Randall, Chief Executive Officer
Adrian Crockett, Chief Financial Officer
Northland Capital Partners Limited (Nominated Adviser and Joint Broker)		+44 (0) 20 3861 6625
Matthew Johnson / Edward Hutton / Margarita Mitropoulou (Corporate Finance)
Bob Pountney / John Howes (Corporate Broking)
Turner Pope Investments (TPI) Ltd (Joint Broker)		+44 (0) 20 3621 4120
James Pope / Ben Turner
Walbrook PR	venturelife@walbrookpr.com or + 44 (0) 20 7933 8780
Paul McManus / Anna Dunphy	+44 (0) 7980 541 893 / +44 (0) 7876 741 001

About Venture Life (www.venture-life.com) 

Venture Life is an international consumer self-care company focused on developing, manufacturing and commercialising products for the ageing population. The Group's product portfolio includes some key products such as the UltraDEX oral care products range, food supplements for lowering cholesterol and maintaining brain function, medical devices for women's intimate healthcare and haemorrhoids and dermo-cosmetics for addressing the signs of ageing.

The products, which are typically recommended by pharmacists or healthcare practitioners, are available primarily through pharmacies supplied by the Group's international distribution partners. 

Through its Development & Manufacturing business in Italy, Biokosmes, the Group also provides development and manufacturing services to companies in the medical devices and cosmetic sectors. 

This information is provided by RNS

The company news service from the London Stock Exchange

END

APPQXLFBDEFZBBF